Table 2

Patient demographics and outcomes for infants born 29–33 weeks’ admitted to neonatal units in England and treated with iNO

2010–20112012–20132014–2015
Neonatal admissions requiring ≥1 day of intensive care (with and without iNO)12 78113 79614 556
Infants treated with iNO144 (1.1%*)315 (2.3%*)693 (4.8%*)
Birth weight (g)1603 (1311,1972)1500 (1290,1800)1500* (1256,1800)
Gestational age (weeks)30 (29,32)31 (29,32)31 (30,32)
Male sex91 (63.2%)187 (59.4%)406 (58.6%)
Prolonged rupture of membranes >24 hours§34 (23.6%)86 (27.3%)124 (17.9%)
Surfactant therapy in labour ward or neonatal unit131 (91.0%)229 (72.7%)418 (60.3%)
Initiation of iNO therapy (days)2 (1,3)3 (1,20)10 (2,24)
Duration of iNO therapy (days)2 (2,4)1 (1,3)1 (1,2)
Diagnosis (not mutually exclusive)‡
Respiratory distresssyndrome92 (63.9%)240 (76.2%)604 (87.2%)
Pulmonary hypoplasia23 (16.0%)46 (14.6%)72 (10.4%)
Pulmonary hypertension76 (52.8%)108 (34.3%)163 (23.5%)
Congenital pneumonia1 (0.7%)3 (1.0%)2 (0.3%)
Congenital diaphragmatic hernia7 (4.9%)11 (3.5%)15 (2.2%)
Death among infants who received iNO59 (41.0%)68 (21.6%)76 (11.0%)
  • The denominator for all proportions is the number of babies treated with iNO unless indicated otherwise.

  • One baby with a birth weight less than 300 grams was removed from this calculation (n=692).

  • *Denominator is all admissions to neonatal unit admissions requiring ≥1 day of intensive care. All values are given as n, % or median (25th, 75th centiles) as appropriate.

  • †This includes the diagnosis respiratory distress syndrome and signs of respiratory distress of newborn (see online supplemental file 1).

  • ‡Extracted codes available in supplementary file.

  • §Prolonged rupture of membranes >24 hours uses a combination of discharge diagnoses and recorded duration of rupture of membranes.

  • iNO, inhaled nitric oxide.